Biogen Inc.

Location

Massachusetts

Founded

1978-02-28

Risk Signals

6605 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Biogen Inc.

Live alerts from global media, monitored by Business Radar

baby boomers spending: The next big market boom? Mizuho analysts say baby boomers' spending, not AI, will be a silver tsunami, to unlock a $1 trillion opportunity -

2025-03-22 (indiatimes.com)

baby boomers spending: The next big market boom? Mizuho analysts say baby boomers' spending, not AI, will be a silver tsunami, to unlock a $1 trillion opportunity -

Mizuho Financial Group analysts reveal that the spending power of America's aging population, particularly those aged 75 and above, will significantly impact the market, unlocking a $1 trillion opportunity, termed "Silver Tsunami."

Read more
New Trends of Bio Pharmaceuticals Market increasing demand,Analysis by Industry Growth Rate, Future Dynamics and Innovative Strategies by 2032 | Abbott Laboratories Amgen Inc., Biogen Inc.

2024-10-10 (openpr.com)

New Trends of Bio Pharmaceuticals Market increasing demand,Analysis by Industry Growth Rate, Future Dynamics and Innovative Strategies by 2032 | Abbott Laboratories Amgen Inc., Biogen Inc.

Press release - Vantage Market Research - New Trends of Bio Pharmaceuticals Market increasing demand,Analysis by Industry Growth Rate, Future Dynamics and Innovative Strategies by 2032 | Abbott Laboratories Amgen Inc., Biogen Inc. - published on openPR.com

Read more
Alzheimer’s Diagnostics and Therapeutics Market to Reach USD 14.8 Billion by 2033, Growing at an 8.4% CAGR – Market Research Blog

2024-09-16 (marketresearchblog.org)

Alzheimer’s Diagnostics and Therapeutics Market to Reach USD 14.8 Billion by 2033, Growing at an 8.4% CAGR – Market Research Blog

The global Alzheimer’s diagnostics and therapeutics market is projected to witness significant growth in the coming decade, reaching an estimated valuation of USD 14.8 billion by 2033. According to a recent study by Future Market Insights, the market is expected to grow from USD 6.6 billion in 2023,

Read more
Gas prices are hurting biotech

2024-04-11 (statnews.com)

Gas prices are hurting biotech

The biggest index of biotech stocks turned red for the year, and it had nothing to do with clinical trials, drug revenues, or pharmaceutical mergers.

Read more
S&P 500 Updates Record, Nasdaq Up 1.5%

2024-03-09 (finmarket.ru)

S&P 500 Updates Record, Nasdaq Up 1.5%

US stock indices ended Tuesday's trading with strong growth. The stock markets of the largest Asia-Pacific countries are generally growing on Wednesday. Oil prices are rising on Wednesday morning, with Brent trading at $82.4 per barrel.

Read more
20 Best Biotech Stocks to Buy in January 2024

2024-01-13 (coinworldstory.com)

20 Best Biotech Stocks to Buy in January 2024

Best Biotech Stocks to Buy in January : Investment in biotech stocks can be an exciting strategy given their constant evolution and rapid advancements in biotec

Read more
Pulmonary Fibrosis Biomarkers Market Anticipates a Remarkable Valuation of US$ 6.2 Billion by 2033-F

2023-11-29 (pharmiweb.com)

Pulmonary Fibrosis Biomarkers Market Anticipates a Remarkable Valuation of US$ 6.2 Billion by 2033-F

The global Pulmonary Fibrosis Biomarkers Market is on a trajectory of substantial growth, with a projected market size of US$ 4.1 billion in 2023 and an anticipated CAGR of 4.2% during the forecast period, propelling it to a valuation of US$ 6.2 billion by 2033.Key to this growth is the rapid adv...

Read more
Investbank

2023-11-14 (finmarket.ru)

Investbank

Investment bank ``Sinara'' maintains ``hold'' rating for Tesla shares with outlook

Read more
Wall St inches up as markets await Fed speakers amid rate-cut hopes

2023-11-06 (indiatimes.com)

Wall St inches up as markets await Fed speakers amid rate-cut hopes

The economic-data calendar for this week is light, with weekly jobless claims numbers due on Thursday and University of Michigans consumer sentiment report on Friday. Walt Disney, Instacart and Biogen are among major companies reporting earnings this week.

Read more
FDA Approves ZURZUVAETM (zuranolone), the First and Only Oral Treatment Approved for Women with Postp

2023-08-05 (pharmiweb.com)

FDA Approves ZURZUVAETM (zuranolone), the First and Only Oral Treatment Approved for Women with Postp

Postpartum depression (PPD) approval based on results from two Phase 3 clinical trials; in the SKYLARK Study treatment with ZURZUVAE rapidly improved symptoms of PPD at Day 15 and as early as Day 3 with sustained effect to Day 45Mental health conditions are the leading cause of maternal mortality...

Read more
2023’s 10 Best-Performing Stocks - WTOP News

2023-08-01 (wtop.com)

2023’s 10 Best-Performing Stocks - WTOP News

The 2023 S&P 500 market rally continued in July as inflation, as measured by a gauge preferred by the Federal Reserve, fell to its lowest level in nearly two years. Investors are becoming increasingly...

Read more
Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points

2023-08-01 (investorplace.com)

Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points

Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.

Read more

Never miss a headline about Biogen Inc.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages